118 related articles for article (PubMed ID: 38329180)
21. Psychological distress and health-related quality of life in patients after hospitalization during the COVID-19 pandemic: A single-center, observational study.
Vlake JH; Wesselius S; van Genderen ME; van Bommel J; Boxma-de Klerk B; Wils EJ
PLoS One; 2021; 16(8):e0255774. PubMed ID: 34379644
[TBL] [Abstract][Full Text] [Related]
22. Health-Related Quality of Life and Depression Symptoms in a Cross Section of Patients with Advanced Lung Cancer before and during the COVID-19 Pandemic.
Petrillo LA; El-Jawahri A; Heuer LB; Post K; Gallagher ER; Trotter C; Elyze M; Vyas C; Plotke R; Turk YR; Han J; Temel JS; Greer JA
J Palliat Med; 2022 Nov; 25(11):1639-1645. PubMed ID: 35588200
[No Abstract] [Full Text] [Related]
23. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
[TBL] [Abstract][Full Text] [Related]
24. Patient-reported outcomes in RELAY, a phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated
Yoh K; Atagi S; Reck M; Garon EB; Ponce Aix S; Moro-Sibilot D; Winfree KB; Frimodt-Moller B; Zimmermann A; Visseren-Grul C; Nakagawa K;
Curr Med Res Opin; 2020 Oct; 36(10):1667-1675. PubMed ID: 32780643
[TBL] [Abstract][Full Text] [Related]
25. Association of Disease Progression With Health-Related Quality of Life Among Adults With Breast, Lung, Pancreatic, and Colorectal Cancer.
Marschner N; Zacharias S; Lordick F; Hegewisch-Becker S; Martens U; Welt A; Hagen V; Gleiber W; Bohnet S; Kruggel L; Dille S; Nusch A; Dörfel S; Decker T; Jänicke M
JAMA Netw Open; 2020 Mar; 3(3):e200643. PubMed ID: 32154886
[TBL] [Abstract][Full Text] [Related]
26. Quality of life with cemiplimab plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: Patient-reported outcomes from phase 3 EMPOWER-Lung 3.
Makharadze T; Quek RGW; Melkadze T; Gogishvili M; Ivanescu C; Giorgadze D; Dvorkin M; Penkov K; Laktionov K; Nemsadze G; Nechaeva M; Rozhkova I; Kalinka E; Gessner C; Moreno-Jaime B; Passalacqua R; Konidaris G; Rietschel P; Gullo G
Cancer; 2023 Jul; 129(14):2256-2265. PubMed ID: 37151113
[TBL] [Abstract][Full Text] [Related]
27. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
28. Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea.
Park JY; Lee YJ; Kim T; Lee CY; Kim HI; Kim JH; Park S; Hwang YI; Jung KS; Jang SH
BMC Cancer; 2020 Oct; 20(1):1040. PubMed ID: 33121456
[TBL] [Abstract][Full Text] [Related]
29. Impact of the COVID-19 pandemic on symptoms of anxiety and depression and health-related quality of life in older patients with chronic kidney disease.
Voorend CGN; van Oevelen M; Nieberg M; Meuleman Y; Franssen CFM; Joosten H; Berkhout-Byrne NC; Abrahams AC; Mooijaart SP; Bos WJW; van Buren M;
BMC Geriatr; 2021 Nov; 21(1):650. PubMed ID: 34798817
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
[TBL] [Abstract][Full Text] [Related]
31. Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON).
Garon EB; Cho BC; Luft A; Alatorre-Alexander J; Geater SL; Kim SW; Ursol G; Hussein M; Lim FL; Yang CT; Araujo LH; Saito H; Reinmuth N; Medic N; Mann H; Shi X; Peters S; Mok T; Johnson M
Lung Cancer; 2023 Dec; 186():107422. PubMed ID: 37992595
[TBL] [Abstract][Full Text] [Related]
32. Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer.
Jarnagin JX; Saraf A; Baiev I; Chi G; van Seventer EE; Mojtahed A; Allen JN; Clark JW; Blaszkowsky L; Giantonio BJ; Weekes CD; Klempner SJ; Franses JW; Roeland EJ; Goyal L; Siravegna G; Horick N; Corcoran RB; Nipp RD; Parikh AR
JAMA Netw Open; 2023 Nov; 6(11):e2343512. PubMed ID: 37976066
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy.
Turner K; Brownstein NC; Thompson Z; El Naqa I; Luo Y; Jim HSL; Rollison DE; Howard R; Zeng D; Rosenberg SA; Perez B; Saltos A; Oswald LB; Gonzalez BD; Islam JY; Tabriz AA; Zhang W; Dilling TJ
Radiother Oncol; 2022 Feb; 167():116-121. PubMed ID: 34953934
[TBL] [Abstract][Full Text] [Related]
34. Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315).
Griesinger F; Sebastian M; Brueckl WM; Hummel HD; Jaeschke B; Kern J; Wesseler C; Jänicke M; Fleitz A; Zacharias S; Hipper A; Groth A; Weichert W; Dörfel S; Petersen V; Schröder J; Wilke J; Eberhardt WEE; Thomas M;
JTO Clin Res Rep; 2024 Apr; 5(4):100626. PubMed ID: 38586301
[TBL] [Abstract][Full Text] [Related]
35. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
[TBL] [Abstract][Full Text] [Related]
36. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
[TBL] [Abstract][Full Text] [Related]
37. Review of Lung Cancer Patient Characteristics and Treatment Strategies in the Pandemic Covid-19 Year.
Crvenkova S; Jakimovki D; Ristovski V
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2023 Mar; 44(1):105-115. PubMed ID: 36987767
[No Abstract] [Full Text] [Related]
38. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
[TBL] [Abstract][Full Text] [Related]
39. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of pembrolizumab for advanced nonsmall cell lung cancer: before and during the COVID-19 pandemic.
Ksienski D; Gupta S; Truong PT; Bone J; Chan A; Alex D; Hart J; Pollock P; Patterson T; Clarkson M; Dissanayake D; Sonke E; Lesperance M
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2951-2961. PubMed ID: 35834010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
